← Back to Halal Checker

NTRA

Natera, Inc.

HALAL
Score: 78/100
stock

Is NTRA Halal?

Genetic diagnostics — prenatal and cancer testing is permissible medical science.

What You Should Know

Natera develops cell-free DNA testing technology used for prenatal screening (Panorama), cancer monitoring (Signatera), and organ transplant rejection detection (Prospera). These are diagnostic tools that help patients and physicians make informed medical decisions. Medical diagnostics is entirely permissible — detecting disease and protecting health (hifz al-nafs) is highly valued in Islamic ethics. Not yet profitable; still investing in commercial scale. Some scholars debate certain genetic testing applications, but diagnostic (not eugenic) uses are generally accepted.

⚠️ Concerns

  • •Not yet profitable — high R&D spending
  • •Prenatal testing used for non-medical decisions by some (application concern, not the product)
  • •Minor interest income on cash
  • •High valuation relative to revenue
🧾
Own NTRA? Purify your portfolio.
Per-holding purification amounts, zakat on your shares, and halal alternatives for flagged holdings — a personalized report prepared for you within 48 hours.
Order Your Report — $49 →
Track NTRA and 30,000+ stocks' live compliance status with Islamicly — 50% off with code ZAKAT50.Get Islamicly →

Similar Stocks

AAPL
Apple Inc.
HALAL87/100
MSFT
Microsoft Corp.
HALAL85/100
TSLA
Tesla, Inc.
HALAL88/100
AMZN
Amazon.com, Inc.
DOUBTFUL62/100
GOOGL
Alphabet Inc. (Google)
DOUBTFUL65/100

Want to screen more assets?

Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.

Go to Halal Checker →